APP and metabolic dysfunction-associated steatotic liver disease: In this study, we hypothesized that NAFLD could reveal the appearance of brain disturbances especially cerebral hypoperfusion in association with dysregulation of plasma and brain lipid metabolism in the APP/PS1 mouse model of AD [33].